Supercritical fluid technology

Handbook of Pharmaceutical Granulation Technology

Volumn , Issue , 2016, Pages 126-137

  Wahl, Martin A ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85131200047     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. Hannay JB, Hogarth J. On the solubility of solids in gases. Proc Roy Soc Lond 1879; 29:1.
2. Krukonis V. Processing of polymers with supercritical fluids. Polym News 1985; 11(1):7-16.
3. Smith RD, inventor (Battelle Memorial Institute, U.S.A., assignee). Supercritical fluid molecular spray film deposition and powder formation. Application: US. US patent 83-528723 4582731. 1986 19830901.
4. Francis AW. Ternary systems of liquid carbon dioxide. J Phys Chem 1954; 58:1099-1114.
5. Mueller BW, Fischer W, inventors; (Schwarz Pharma GmbH, Fed Rep Ger, assignee). Manufacture of sterile sustained-release drug formulations using liquefied gases. Application: DE. DE patent 87-3744329 3744329. 1989 19871228.
6. Jung J, Perrut M. Particle design using supercritical fluids: literature and patent survey. J Supercrit Fluids 2001; 20(3):179-219.
7. Arai Y, Sako T, Takebayashi Y. Supercritical Fluids. Berlin, Heidelberg, New York: Springer, 2002: 71-126.
8. Martinez JL. Supercritical Fluid Extraction of Neutraceuticals and Bioactive Compounds. Boca Raton, London, New York: CRC Press, 2008:1-24.
9. Cabanas A, Renuncio JAR, Pando C. Thermodynamic study of the N2O + CO2 and N2O + CO2 + cyclohexane systems in the near-critical and supercritical regions. Ind Eng Chem Res 2000; 39(10): 3566-3575.
10. Tillner-Roth R, Baehr HD. Measurement of liquid, near-critical, and supercritical (p, r, T) of 1,1,1,2-tetrafluoroethane (R 134a) and of 1,1-difluoroethane (R 152a). J Chem Thermodyn 1993; 25(2):277-292.
11. Saitow K, Kajiya D, Nishikawa K. Dynamics of density fluctuation of supercritical fluid mapped on phase diagram. J Am Chem Soc 2004; 126(2):422-423.
12. Ohgaki K, Katayama T. Isothermal vapor-liquid equilibrium data for binary systems containing carbon dioxide at high pressures: methanol-carbon dioxide, n-hexane-carbon dioxide, and benzene-carbon dioxide systems. J Chem Eng Data 1974; 21(1):3.
13. Chiu K-H, Yak HK, Wang JS, et al. Supercritical fluid extraction of mixed wastes. Green Chem 2004; 6 (10):502-506.
14. Subra P, Castellani S, Ksibi H, et al. Contribution to the determination of the solubility of beta-carotene in supercritical carbon dioxide and nitrous oxide: experimental data and modeling. Fluid Phase Equilibria 1997; 131(1-2):269-286.
15. Sievers RE, Hansen B. Supercritical fluid nitrous explosion. Chem Eng News 1991; 69:1.
16. Abbott AP, Eardley CA. Solvent properties of liquid and supercritical 1,1,1,2-tetrafluoroethane. J Phys Chem B 1998; 102(43):8574-8578.
17. Corr S. 1,1,1,2-tetrafluoroethane (R-134a): a selective solvent for the generation of flavor and fragrance ingredients. ACS Symp Ser 2005; 908:41-59.
18. Türk M, Hils P, Helfgen B, et al. Micronization of pharmaceutical substances by the Rapid Expansion of Supercritical Solutions (RESS): a promising method to improve bioavailability of poorly soluble pharmaceutical agents. J Supercrit Fluids 2002; 22(1):75-84.
19. Weinstein RD, Muske KR, Moriarty J, et al. The solubility of benzocaine, lidocaine, and procaine in liquid and supercritical carbon dioxide. J Chem Eng Data 2004; 49(3):547-552.
20. York P, Kompella UB, Shekunov BY. Supercritical Fluid Technology for Drug Product Development. New York, Basel: Marcel Dekker, 2004:1-27.
21. Gupta RB, Shim J-J. Solubility in Supercritical Carbon Dioxide. Boca Raton, London, New York: CRC Press, 2007.
22. Gosselin PM, Thibert R, Preda M, et al. Polymorphic properties of micronized carbamazepine produced by RESS. Int J Pharm 2003; 252(1-2):225-233.
23. Türk M. Manufacture of submicron drug particles with enhanced dissolution behaviour by rapid expansion processes. J Supercrit Fluids 2009; 47(3):537-545.
24. Helfgen B, Türk M, Schaber K. Hydrodynamic and aerosol modelling of the rapid expansion of supercritical solutions (RESS-process). J Supercrit Fluids 2003; 26(3):225-242.
25. Debenedetti PG, Tom JW, Yeo S, et al. Application of supercritical fluids for the production of sustained delivery devices. J Control Release 1993; 24(1-3):27-44.
26. Domingo C, Wubbolts FE, Rodriguez-Clemente R, et al. Solid crystallization by rapid expansion of supercritical ternary mixtures. J Cryst Growth 1999; 198/199 (pt 1):760-766.
27. Thakur R, Gupta RB. Formation of phenytoin nanoparticles using rapid expansion of supercritical solution with solid cosolvent (RESS-SC) process. Int J Pharm 2006; 308(1-2):190-199.
28. Bettini R, Rossi A, Lavezzini E, et al. Thermal and morphological characterization of micronized acetylsalicylic acid powders prepared by rapid expansion of a supercritical solution. J Therm Anal Calorim 2003; 73(2):487-497.
29. Charpentier Paul A, Jia M, Lucky Rahima A. Study of the RESS process for producing beclomethasone-17,21-dipropionate particles suitable for pulmonary delivery. AAPS Pharm Sci Tech 2008; 9(1):39-46.
30. Chu J, Li G, Row KH, et al. Preparation of cefpodoxime proxetil fine particles using supercritical fluids. Int J Pharm 2009; 369(1-2):85-91.
31. Varshosaz J, Hassanzadeh F, Mahmoudzadeh M, et al. Preparation of cefuroxime axetil nanoparticles by rapid expansion of supercritical fluid technology. Powder Technol 2009; 189(1):97-102.
32. Tandya A, Dehghani F, Foster NR. Micronization of cyclosporine using dense gas techniques. J Supercrit Fluids 2006; 37(3):272-278.
33. Della Porta G, Ercolino SF, Parente L, et al. Corticosteroid microparticles produced by supercritical-assisted atomization: process optimization, product characterization, and "in vitro" performance. J Pharm Sci 2006; 95(9):2062-2076.
34. Chingunpitak J, Puttipipatkhachorn S, Tozuka Y, et al. Micronization of dihydroartemisinin by rapid expansion of supercritical solutions. Drug Dev Ind Pharm 2008; 34(6):609-617.
35. Chiou AH-J, Cheng H-C, Wang D-P. Micronization and microencapsulation of felodipine by supercritical carbon dioxide. J Microencapsul 2006; 23(3):265-276.
36. Reverchon E, Della Porta G, Taddeo R, et al. Solubility and micronization of griseofulvin in supercritical CHF3. Ind Eng Chem Res 1995; 34(11):4087-4091.
37. Ghaderi R, Artursson P, Carlfors J. A new method for preparing biodegradable microparticles and entrapment of hydrocortisone in dl-PLG microparticles using supercritical fluids. Eur J Pharm Sci 2000; 10(1):1-9.
38. Snavely WK, Subramaniam B, Rajewski RA, et al. Micronization of insulin from halogenated alcohol solution using supercritical carbon dioxide as an antisolvent. J Pharm Sci 2002; 91(9):2026-2039.
39. Amidi M, Pellikaan HC, de Boer AH, et al. Preparation and physicochemical characterization of supercritically dried insulin-loaded microparticles for pulmonary delivery. Eur J Pharm Biopharm 2008; 68(2):191-200.
40. Elvassore N, Bertucco A, Caliceti P. Production of insulin-loaded poly(ethylene glycol)/poly (L-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques. J Pharm Sci 2001; 90(10):1628-1636.
41. Charoenchaitrakool M, Dehghani F, Foster NR, et al. Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals. Ind Eng Chem Res 2000; 39(12):4794-4802.
42. Cai M-Q, Guan Y-X, Yao S-J, et al. Supercritical fluid assisted atomization introduced by hydrodynamic cavitation mixer (SAA-HCM) for micronization of levofloxacin hydrochloride. J Supercrit Fluids 2008; 43(3):524-534.
43. Chiou AH-J, Yeh M-K, Chen C-Y, et al. Micronization of meloxicam using a supercritical fluids process. J Supercrit Fluids 2007; 42(1):120-128.
44. Kim J-H, Paxton TE, Tomasko DL. Microencapsulation of naproxen using rapid expansion of supercritical solutions. Biotechnol Prog 1996; 12(5):650-661.
45. Sencar-Bozic P, Srcic S, Knez Z, et al. Improvement of nifedipine dissolution characteristics using supercritical CO2. Int J Pharm 1997; 148(2):123-130.
46. Shinozaki H, Oguchi T, Suzuki S, et al. Micronization and polymorphic conversion of tolbutamide and barbital by rapid expansion of supercritical solutions. Drug Dev Ind Pharm 2006; 32(7):877-891.
47. Perrut M, Jung J, Leboeuf F. Enhancement of dissolution rate of poorly-soluble active ingredients by supercritical fluid processes. Part I. Micronization of neat particles. Int J Pharm 2005; 288(1):3-10.
48. Cocero MJ, Martin A, Mattea F, et al. Encapsulation and co-precipitation processes with supercritical fluids: fundamentals and applications. J Supercrit Fluids 2009; 47(3):546-555.
49. Wendt T, Brandin G, Kilzer A, et al. Manufacture of powdered multiphase composite coatings by the methods of particles from gas saturated solutions (PGSS). Chem Ind Technol 2007; 79(3):287-295.
50. Reverchon E, Adami R, Cardea S, et al. Supercritical fluids processing of polymers for pharmaceutical and medical applications. J Supercrit Fluids 2009; 47(3):484-492.
51. Reverchon E, De Marco I, Torino E. Nanoparticles production by supercritical antisolvent precipitation: a general interpretation. J Supercrit Fluids 2007; 43(1):126-138.
52. Yeo SD, Debenedetti PG, Radosz M, et al. Supercritical antisolvent process for substituted para-linked aromatic polyamides: phase equilibrium and morphology study. Macromolecules 1993; 26(23): 6207-6210.
53. Martin A, Scholle K, Mattea F, et al. Production of polymorphs of ibuprofen sodium by supercritical antisolvent (SAS) precipitation. Cryst Growth Des 2009; 9(5):2504-2511.
54. Shekunov BY, York P, Baldyga J. Particle formation using supercritical antisolvent: influence of flow velocity and supersaturation. Int Symp Ind Cryst 1999; 1112-1126.
55. Song KH, Lee C-H, Lim JS, et al. Preparation of PLLA submicron particles by a continuous supercritical antisolvent precipitation process. Korean J Chem Eng 2002; 19(1):139-145.
56. Subra P, Jestin P. Screening design of experiment (DOE) applied to supercritical antisolvent process. Ind Eng Chem Res 2000; 39(11):4178-4184.
57. Huang J, Moriyoshi T. Fabrication of fine powders by RESS with a clearance nozzle. J Supercrit Fluids 2006; 37(3):292-297.
58. Tandya A, Mammucari R, Dehghani F, et al. Dense gas processing of polymeric controlled release formulations. Int J Pharm 2007; 328(1):1-11.
59. Türk M, Upper G, Steurenthaler M, et al. Complex formation of Ibuprofen and beta-cyclodextrin by controlled particle deposition (CPD) using SC-CO2. J Supercrit Fluids 2007; 39(3):435-443.
60. Hussein K, Türk M, Wahl MA. Comparative evaluation of Ibuprofen/beta-cyclodextrin complexes obtained by supercritical carbon dioxide and other conventional methods. Pharm Res 2007; 24(3): 585-592.
61. Hussein K, Türk M, Wahl MA. Drug loading into beta-cyclodextrin granules using a supercritical fluid process for improved drug dissolution. Eur J Pharm Sci 2008; 33(3):306-312.
62. Wischumerski RS, Türk M, Wahl MA. Direct drug loading into preformed porous solid dosage units by the controlled particle deposition (CPD), a new concept for improved dissolution using SCF-technology. J Pharm Sci 2008; 97(10):4416-4424.
63. Van Hees T, Piel G, Evrard B, et al. Application of supercritical carbon dioxide for the preparation of a piroxicam-beta-cyclodextrin inclusion compound. Pharm Res 1999; 16(12):1864-1870.
64. Charoenchaitrakool M, Dehghani F, Foster NR. Utilization of supercritical carbon dioxide for complex formation of ibuprofen and methyl-beta-cyclodextrin. Int J Pharm 2002; 239(1-2):103-112.
65. Duarte Ana Rita C, Costa Mariana S, Simplicio Ana L, et al. Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs. Int J Pharm 2006; 308(1-2):168-174.
66. Kikic I, Sist P. Applications of supercritical fluids to pharmaceuticals: controlled drug release systems. NATO Sci Ser Ser E 2000; 366:291-306.
67. Weidner E. High pressure micronization for food applications. J Supercrit Fluids 2009; 47:9.
68. Smirnova I, Suttiruengwong S, Arlt W. Feasibility study of hydrophilic and hydrophobic silica aerogels as drug delivery systems. J Non-Cryst Solids 2004; 350:6.
69. Smirnova I, Türk M, Wischumerski R, et al. Comparison of different methods for enhancing the dissolution rate of poorly soluble drugs: case of griseofulvin. Eng Life Sci 2005; 5(3):277-280.
70. Chattopadhyay P, Shekunov BY. Supercritical fluid: new enabling technologies for drug delivery. Drug Delivery Technol 2006; 6(8):64-68.
71. Della Porta G, Reverchon E. Nanostructured microspheres produced by supercritical fluid extraction of emulsions. Biotechnol Bioeng 2008; 100(5):1020-1033.
72. Türk M. Studies of the coating of submicron particles by the CORESS process. Chem Ind Technol 2004; 76(6):835-838.
73. Weidner E, Steiner R, Knez Z. Powder generation from polyethylene glycols with compressible fluids. Process Technol Proc 1996; 12:223-228.
74. Wang Y, Wang Y, Yang J, et al. The application of a supercritical antisolvent process for sustained drug delivery. Powder Technol 2006; 164(2):94-102.